tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cencora Reports Strong Q3 2025 Financial Results

Story Highlights
  • Cencora reported an 8.7% revenue increase to $80.7 billion in Q3 2025.
  • The company’s adjusted EPS guidance for fiscal 2025 was raised due to strategic growth initiatives.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cencora Reports Strong Q3 2025 Financial Results

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from Cencora ( (COR) ) is now available.

On August 6, 2025, Cencora announced its fiscal third-quarter results for 2025, reporting an 8.7% increase in revenue to $80.7 billion compared to the previous year. The company’s GAAP diluted EPS rose to $3.52, while adjusted diluted EPS increased to $4.00, leading to an upward revision of its fiscal 2025 EPS guidance. The growth was attributed to strategic acquisitions and a focus on digital transformation, talent investment, and productivity, enhancing its position as a preferred partner in the healthcare sector.

The most recent analyst rating on (COR) stock is a Buy with a $250.00 price target. To see the full list of analyst forecasts on Cencora stock, see the COR Stock Forecast page.

Spark’s Take on COR Stock

According to Spark, TipRanks’ AI Analyst, COR is a Outperform.

Cencora’s strong financial performance and positive earnings outlook are key strengths, despite high leverage and valuation concerns. Recent corporate events enhance liquidity and flexibility, supporting a favorable overall outlook.

To see Spark’s full report on COR stock, click here.

More about Cencora

Cencora, Inc. operates in the healthcare industry, focusing on pharmaceutical-centric strategies. It provides healthcare solutions through its U.S. and International Healthcare Solutions segments, offering products and services that cater to market growth, including specialty products and those for diabetes and weight loss.

Average Trading Volume: 1,400,530

Technical Sentiment Signal: Buy

Current Market Cap: $55.89B

Find detailed analytics on COR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1